Back to Journals » Drug Design, Development and Therapy » Volume 9

Original Research

Small-molecule BH3 mimetic and pan-Bcl-2 inhibitor AT-101 enhances the antitumor efficacy of cisplatin through inhibition of APE1 repair and redox activity in non-small-cell lung cancer

       
Total article views   HTML views PDF downloads Totals
11,650 Dovepress* 10,018+ 1,694 11,712
PubMed Central* 1,632 442 2,074
Totals 11,650 2,136 13,786
*Since 8 June 2015
+Since July 2016

View citations on PubMed Central and Google Scholar